authors
- Naci, Huseyin
- Shahzad, Mahnum
- Murphy, Peter
- Zhang, Yichen
- Costa, Rebecca
- Joseph S. Ross, MD, MHS
- Wagner, Anita K
Costs and benefits of early access to new cancer drugs through the US Food and Drug Administration's accelerated approval pathway: retrospective observational study and economic evaluation.
- Overview
- Research
- Identity
- Additional Document Info
- View All